Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Squamous Carcinoma Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07435454
What this trial is testing

Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Jiangsu Cancer Institute & Hospital 22
Not applicableLooking for participantsNCT02972372
What this trial is testing

Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer

Who this might be right for
Esophagus Cancer
The First Affiliated Hospital of Henan University of Science and Technology 196
Testing effectiveness (Phase 2)UnknownNCT04437212
What this trial is testing

Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer

Who this might be right for
Advanced Esophageal Squamous Cell Cancer
RenJi Hospital 20
Not applicableUnknownNCT06410677
What this trial is testing

Changhai Multimodal Esophageal Cancer Cohort

Who this might be right for
Esophageal Squamous Cell Carcinoma
Wangluowei 110
Testing effectiveness (Phase 2)UnknownNCT05626569
What this trial is testing

Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaOligometastatic Disease
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Study completedNCT03719924
What this trial is testing

Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma
Federation Francophone de Cancerologie Digestive 106
Testing effectiveness (Phase 2)UnknownNCT05394415
What this trial is testing

Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaTislelizumabChemoradiation
Jiangsu Cancer Institute & Hospital 30
Not applicableStudy completedNCT05557955
What this trial is testing

Identification of Breath Biomarkers in Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Mian XI 210
Testing effectiveness (Phase 2)Ended earlyNCT03251417
What this trial is testing

Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 11
Not applicableActive Not RecruitingNCT06828718
What this trial is testing

The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC）

Who this might be right for
Esophageal Carcinoma
Hebei Medical University Fourth Hospital 1,000
Large-scale testing (Phase 3)UnknownNCT02461043
What this trial is testing

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Chinese Academy of Medical Sciences 386
Not applicableStudy completedNCT01551589
What this trial is testing

Involved Field Irradiation (IFI) Versus Elective Nodal Irradiation (ENI) for Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Chengya Chou 220
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07678580
What this trial is testing

Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tang-Du Hospital 50
Not applicableUnknownNCT04229524
What this trial is testing

Quantitative Assessment of Blood Supply in the Gastic Conduit With Fluorescence Angiography for Esophageal Reconstruction

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute 246
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Not applicableUnknownNCT00766480
What this trial is testing

Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus

Who this might be right for
Esophageal Cancer
University of Toyama 160
Testing effectiveness (Phase 2)UnknownNCT05596890
What this trial is testing

Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients

Who this might be right for
Esophageal Squamous Cell CarcinomaPatient-reported OutcomesImmunotherapy
Guangdong Provincial People's Hospital 50
Not applicableStudy completedNCT03081715
What this trial is testing

PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Hangzhou Cancer Hospital 16
Early research (Phase 1)Ended earlyNCT04116320
What this trial is testing

Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors

Who this might be right for
MelanomaBreast CancerMerkel Cell Carcinoma+10 more
Craig L Slingluff, Jr 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128693
What this trial is testing

A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumotecan in Patients With Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 60
Next Page